XAIR (Beyond Air) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XAIR Beyond Air Inc XAIR
25 GF Score
Price $5.54
GF Value $134.81
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Beyond Air FFO per Share?

FFO per Share only applies to REITs.

XAIR
25GF Score
Beyond Air Inc XAIR
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beyond Air (XAIR) Overvalued in 2026?

Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued. The current stock price of $5.54 is trading 95.9% below its estimated GF Value™ of $134.81. GuruFocus considers Beyond Air to be Possible Value Trap.

Key valuation signals for XAIR:

  • FFO per Share:
  • GF Value™: $134.81 vs. price of $5.54 (95.9% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the XAIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beyond Air Business Description

Address 900 Stewart Avenue, Suite 301, Garden City, New York, NY, USA, 11530
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
25GF Score

Get the complete analysis for XAIR

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.54
Price
$134.81
GF Value